IMARC Group has recently released a report titled “Dry Age Macular Degeneration Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033” that presents a comprehensive assessment of the dry age macular degeneration market size, latest trends, and growth forecast. The report provides an overview of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market scenario, and growth trends. In addition, the report offers competitor analysis, regional analysis, and recent advancements in the global market. The report also highlights key segments and market drivers, as well as challenges faced by industry players.
Dry age macular degeneration refers to a common eye disorder that mostly affects individuals as they age. This condition causes thinning of the macula’s inner layers, which are responsible for detail perception as well as central and color visions. Individuals suffering from this ailment may experience a need for brighter light when reading or making close work, blank or dark spots in the field of vision, straight lines looking crooked or wavy, increased difficulty adapting to low light levels, blurred or diminished central vision, etc. The diagnosis of dry age macular degeneration typically requires a review of the patient’s symptoms, medical history, and dilated eye examination.
Request a Free Sample Report: https://www.imarcgroup.com/dry-age-macular-degeneration-market/requestsample
Market Trend:
The expanding geriatric population, which is susceptible to the degradation of cells in the macula, thereby resulting in scarring of the retina, is primarily stimulating the dry age macular degeneration market. Additionally, the elevating prevalence of several associated risk factors, such as high blood pressure, an inadequate diet, smoking, obesity, etc., is further catalyzing the market growth. Besides this, the escalating demand for antioxidant vitamins and minerals, including beta-carotene, vitamins C and E, zinc, copper, etc., which minimize cellular damage by deactivating free radicals in the retina, is acting as another significant growth-inducing factor. Furthermore, the growing adoption of anti-angiogenic drugs, like ranibizumab and aflibercept, that can be directly injected into the eye to help slow the progression of abnormal blood vessels is also contributing to the market growth. Apart from this, the inflating utilization of laser photocoagulation therapy on account of its several advantages, including resolution of drusen, prevention of vision loss, and improvement in quality of life for affected people, is projected to bolster the dry age macular degeneration market over the forecasted period.
Report Period:
- Base Year: 2022
- Historical Period: 2017-2022
- Market Forecast: 2023-2033
Countries Included:
- United States
- Germany
- France
- United Kingdom
- Italy
- Spain
- Japan
Analysis Covered Across Each Country
- Historical, current, and future epidemiology scenario
- Historical, current, and future performance of the dry age macular degeneration market
- Historical, current, and future performance of various therapeutic categories in the market
- Sales of various drugs across the dry age macular degeneration market
- Reimbursement scenario in the market
- In-market and pipeline drugs
In-Market Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Regulatory Status
Ask an Analyst for Report Customization with TOC & List of figures: https://www.imarcgroup.com/dry-age-macular-degeneration-market
Key Questions Answered in this Report:
- How has the dry age macular degeneration market performed so far and how will it perform in the coming years?
- What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
- What was the country-wise size of the dry age macular degeneration market across the seven major markets in 2022 and what will it look like in 2033?
- What is the growth rate of the dry age macular degeneration market across the seven major markets and what will be the expected growth over the next ten years?
- What are the key unmet needs in the market?
Browse the Latest Research Report:
Gonorrhea Market Report 2023-2033
Drug-Resistant Epilepsy Market Report 2023-2033
Acute Coronary Syndrome Market Report 2023-2033
Abscess Market Report 2023-2033
Hemophilia A Market Report 2023-2033
Significant Benefits of the Report to Stakeholders:
- Individuals directly or indirectly involved in the value chain of the dry age macular degeneration market can gain valuable insights into key players and major market trends, enabling them to stay up-to-date and make informed decisions.
- Professionals responsible for selecting a dry age macular degeneration market for large and enterprise-level organizations can conduct thorough due diligence by leveraging the comprehensive information provided in this report.
- Those seeking current intelligence on the dynamic dry age macular degeneration market can benefit from the report’s valuable insights, helping them stay informed and make strategic business decisions.
- Companies operating in the dry age macular degeneration market can benchmark and assess their market position and standing against their competitors, gaining a strategic viewpoint to evaluate and adapt to the changing market landscape.
About Us: –
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
